Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Microbiology of the built environment.
Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Microbiology of the built environment.
Microbiology of the built environment. Nat Rev Microbiol. 2018 11; 16(11):661-670.
View in:
PubMed
subject areas
Adaptation, Biological
Animals
Archaea
Bacteria
Biological Evolution
Ecology
Ecosystem
Fungi
Humans
Microbiology
Microbiota
Public Health
Viruses